טוען...
Generation and characterization of aptamers targeting factor XIa
BACKGROUND: The plasma protease factor XIa (FXIa) has become a target of interest for therapeutics designed to prevent or treat thrombotic disorders. METHODS: We used a solution-based, directed evolution approach called systematic evolution of ligands by exponential enrichment (SELEX) to isolate RNA...
שמור ב:
| הוצא לאור ב: | Thromb Res |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697752/ https://ncbi.nlm.nih.gov/pubmed/28644959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2017.06.015 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|